Kymera Therapeutics (KYMR) EBIT Margin Growth (1y) (2020 - 2026)
Kymera Therapeutics (KYMR) EBIT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Kymera Therapeutics |
8.84 Bn |
8.19 Bn |
- |
9,189.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
9,189.00 |
| Dec 31, 2025 |
-231,884.00 |
| Sep 30, 2025 |
-141,943.00 |
| Jun 30, 2025 |
-53,828.00 |
| Mar 31, 2025 |
22,541.00 |
| Dec 31, 2024 |
-105,184.00 |
| Sep 30, 2024 |
-71,158.00 |
| Jun 30, 2024 |
6,418.00 |
| Mar 31, 2024 |
-8,335.00 |
| Dec 31, 2023 |
19,903.00 |
| Sep 30, 2023 |
-74,643.00 |
| Jun 30, 2023 |
9,172.00 |
| Mar 31, 2023 |
-9,499.00 |
| Dec 31, 2022 |
-1,681.00 |
| Sep 30, 2022 |
-32,910.00 |
| Jun 30, 2022 |
-22,090.00 |
| Mar 31, 2022 |
-31,342.00 |
| Dec 31, 2021 |
-12,257.00 |
| Sep 30, 2021 |
-8,520.00 |
| Jun 30, 2021 |
29,809.00 |
